Case Study of Medicines for Malaria Venture

Written By Miranda Sieg, Former Staff Writer
6.-Malaria.jpg

This case study will analyze the public-private partnership (PPP), Medicines for Malaria Venture (MMV). A PPP is a relatively new business model and due the novelty of the organizational structure and function, its impact on global health efforts needs to be assessed. In the following analysis, the structure, function, and governance of MMV will be explored along with the institutional interactions with other international health organizations. Through the assessment of MMV, the background of the organization, MDG-related activities, and opportunities for reform and strengthening of the global health efforts will be recommended. For the purpose of this case study, the global health related efforts of MMV will be analyzed, particularly in the context of the Millennium Development Goals (MDGs) with the primary focus on MDG 6: Combat HIV/AIDS, malaria and other diseases. This image is being used under Creative Commons licensing. The original source can be found here.

Miranda Sieg, Former Staff Writer

Miranda Sieg is a second-year Masters Student at the George Washington University Elliott School of International Affairs studying Security, Development and Conflict Resolution. She is primarily focused on education and cross-cultural violence issues in East and Southeast Asia, but has recently developed an interest in post-conflict development and the integration of refugees and at risk migrants. Miranda spent two and a half years studying and working in Japan and traveling extensively in East and Southeast Asia. She currently works for the International Education Program at GW and is a Presidential Management Fellow Finalist and GW UNESCO Fellow.

Previous

Aid Collaboration in Uganda
Next

Russian new media will not lead to Egypt-style revolts